Raptiva for psoriasis

Patients will soon be able to use Raptiva for psoriasis.

Raptiva (efalizumab) is a new biotech drug. It's an antibody that blocks T-cells that play a role in psoriasis.

It's similar to the psoriasis drug, Amevive (alefacept)... but each drug blocks different T-cell receptors.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote